InvestorsHub Logo
Followers 105
Posts 4897
Boards Moderated 0
Alias Born 10/06/2011

Re: Drugdoctor post# 167277

Tuesday, 10/20/2015 9:53:19 AM

Tuesday, October 20, 2015 9:53:19 AM

Post# of 400066
I am an investor not a trader. Still, I pay attention to the share prices and there seems to be an inordinate focus on the Elite’s p/s, as if the “wild swings” from 21 cents to 26 cents and back is reflective of anything more than smoke and mirror magic. What is disingenuous is the argument that this somehow reflects the value of Elite and that, since it is stuck in a trading channel, it somehow negates the science. Specifically that would be the science that has led to the patents and successful trials, as well as the P-3 for which results are pending. For those who are truly confused, allow me to offer the following…

Analysts have commented on the current downturn in pharma stocks and suggested the pullback has been exacerbated by those engaged in high frequency trading and who focus on chart patterns, not fundamentals. The problem is that, while the chart patterns in the sector do not look good, many of the companies are strong financially and their science is sound. (Their chart analysis may reflect the “Texas Sharpshooters Fallacy” https://en.wikipedia.org/wiki/Texas_sharpshooter_fallacy) Then there is the link below that supports the argument that short-term price news is of greatest importance to traders, while it only matters to investors on two occasions; when they buy and when they sell. The link is a good read and I would not insult anyone by quoting what they can read for themselves…

http://stocks.about.com/od/evaluatingstocks/a/2013-08-07-Stock-Value-And-Price-Are-Not-The-Same.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News